Akkermansia muciniphila and Parabacteroides distasonis synergistically protect from colitis by promoting ILC3 in the gut
mBio · 10.04.2024 · 15 (4)
DOI: 10.1128/mbio.00078-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 10.04.2024. Verfasst von Joana Gaifem und 14 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. Hauptthemen laut MEDLINE: Colitis, Inflammatory Bowel Diseases, Bacteroidetes. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEC | Fundação para a Ciência e a Tecnologia (FCT), Fonds National de la Recherche Luxembourg (FNR), Ministerio de Ciencia e Innovación (MCIN).
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the gastrointestinal tract. The etiology of IBD remains elusive, but the disease is suggested to arise from the interaction of environmental and genetic factors that trigger inadequate immune responses and inflammation in the intestine. The gut microbiome majorly contributes to disease as an environmental variable, and although some causative bacteria are identified, little is known about which specific members of the microbiome aid in the intestinal epithelial barrier function to protect from disease. While chemically inducing colitis in mice from two distinct animal facilities, we serendipitously found that mice in one facility showed remarkable resistance to disease development, which was associated with increased markers of epithelial barrier integrity. Importantly, we show that Akkermansia muciniphila and Parabacteroides distasonis were significantly increased in the microbiota of resistant mice. To causally connect these microbes to protection against disease, we colonized susceptible mice with the two bacterial species. Our results demonstrate that A. muciniphila and P . distasonis synergistically drive a protective effect in both acute and chronic models of colitis by boosting the frequency of type 3 innate lymphoid cells in the colon and by improving gut epithelial integrity. Altogether, our work reveals a combined effort of commensal microbes in offering protection against severe intestinal inflammation by shaping gut immunity and by enhancing intestinal epithelial barrier stability. Our study highlights the beneficial role of gut bacteria in dictating intestinal homeostasis, which is an important step toward employing microbiome-driven therapeutic approaches for IBD clinical management. IMPORTANCE The contribution of the gut microbiome to the balance between homeostasis and inflammation is widely known. Nevertheless, the etiology of inflammatory bowel disease, which is known to be influenced by genetics, immune response, and environmental cues, remains unclear. Unlocking novel players involved in the dictation of a protective gut, namely, in the microbiota component, is therefore crucial to develop novel strategies to tackle IBD. Herein, we revealed a synergistic interaction between two commensal bacterial strains, Akkermansia muciniphila and Parabacteroides distasonis , which induce protection against both acute and chronic models of colitis induction, by enhancing epithelial barrier integrity and promoting group 3 innate lymphoid cells in the colonic mucosa. This study provides a novel insight on how commensal bacteria can beneficially act to promote intestinal homeostasis, which may open new avenues toward the use of microbiome-derived strategies to tackle IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
- ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
- i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
- Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
- Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia, Spain.
ORCID-Profile: Joana Gaifem, Agostinho Carvalho, Mahesh S Desai, Fernando Rodrigues, Ricardo Silvestre
Förderung
- MEC | Fundação para a Ciência e a Tecnologia (FCT)
- Fonds National de la Recherche Luxembourg (FNR)
- Ministerio de Ciencia e Innovación (MCIN)
- GVA | Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (CIUCSD)
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
- European Crohn's and Colitis Organisation (ECCO)
Zitieren
APA
Gaifem, J., Mendes-Frias, A., Wolter, M., Steimle, A., Garzón, M. J., Ubeda, C., Nobre, C., González, A., Pinho, S. S., Cunha, C., Carvalho, A., Castro, A. G., Desai, M. S., Rodrigues, F., & Silvestre, R. (2024). Akkermansia muciniphila and Parabacteroides distasonis synergistically protect from colitis by promoting ILC3 in the gut. mBio, 15(4). https://doi.org/10.1128/mbio.00078-24
Vancouver
Gaifem J, Mendes-Frias A, Wolter M, Steimle A, Garzón MJ, Ubeda C, et al. Akkermansia muciniphila and Parabacteroides distasonis synergistically protect from colitis by promoting ILC3 in the gut. mBio. 2024;15(4). doi:10.1128/mbio.00078-24
BibTeX
@article{Gaifem2024,
author = {Gaifem, Joana and Mendes-Frias, Ana and Wolter, Mathis and Steimle, Alex and Garzón, Maria Jose and Ubeda, Carles and Nobre, Clarisse and González, Abigail and Pinho, Salomé S and Cunha, Cristina and Carvalho, Agostinho and Castro, António Gil and Desai, Mahesh S and Rodrigues, Fernando and Silvestre, Ricardo},
title = {Akkermansia muciniphila and Parabacteroides distasonis synergistically protect from colitis by promoting ILC3 in the gut},
journal = {mBio},
year = {2024},
volume = {15},
number = {4},
doi = {10.1128/mbio.00078-24}
}
EUVIMED